4d Molecular Therapeutics In shares owned by Arrowpoint Asset Management
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Arrowpoint Asset Management
from 13F filings
Historical chart of Arrowpoint Asset Management investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by Arrowpoint Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in 4d Molecular Therapeutics In by Arrowpoint Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $24M | 1.2M | 20.26 |
| 2023-09-30 | $14M | 1.1M | 12.73 |
| 2023-06-30 | $19M | 1.0M | 18.07 |
| 2023-03-31 | $18M | 1.0M | 17.19 |
| 2022-12-31 | $22M | 982k | 22.21 |
| 2022-09-30 | $12M | 1.5M | 8.04 |
| 2022-06-30 | $9.9M | 1.4M | 6.98 |
| 2022-03-31 | $17M | 1.1M | 15.12 |
| 2021-12-31 | $24M | 1.1M | 21.94 |
| 2021-09-30 | $27M | 1.0M | 26.97 |
| 2021-06-30 | $25M | 1.0M | 24.08 |
| 2021-03-31 | $46M | 1.0M | 43.38 |
| 2020-12-31 | $44M | 1.1M | 41.45 |
More positions owned by Arrowpoint Asset Management
View all positions for Arrowpoint Asset Management